6286-88-0 Usage
Type of compound
Chemical compound
Derivative of
Benzoic acid
Contains
Carbazole group
Carbazole group structure
Fused heterocyclic compound composed of two six-membered rings and a five-membered ring
Potential applications
Organic synthesis and material science
Unique structure
Contributes to its potential applications
Possible use in
Development of organic electronic devices
Examples of organic electronic devices
Organic light-emitting diodes (OLEDs) and organic photovoltaic cells
Potential properties for devices
Electron transport and semiconducting properties
Additional applications
Pharmaceuticals and agrochemicals
Role in pharmaceuticals and agrochemicals
Potential for biological activity and synthesis of complex organic compounds
Check Digit Verification of cas no
The CAS Registry Mumber 6286-88-0 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,2,8 and 6 respectively; the second part has 2 digits, 8 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 6286-88:
(6*6)+(5*2)+(4*8)+(3*6)+(2*8)+(1*8)=120
120 % 10 = 0
So 6286-88-0 is a valid CAS Registry Number.
6286-88-0Relevant articles and documents
Hydrogen bonding boosted the persistent room temperature phosphorescence of pure organic compounds for multiple applications
Zhang, Tingting,Gao, Heqi,Lv, Anqi,Wang, Ziyi,Gong, Yongyang,Ding, Dan,Ma, Huili,Zhang, Yongming,Yuan, Wang Zhang
, p. 9095 - 9101 (2019)
Persistent room temperature phosphorescence (p-RTP) of pure organic compounds is drawing much attention due to its unique advantages and promising applications in anticounterfeiting, encryption, bioimaging, etc. Achieving efficient p-RTP, however, remains
PYRROL-1 -YL BENZOIC ACID DERIVATES USEFUL AS MYC INHIBITORS
-
Paragraph 00340, (2014/05/24)
The present invention provides compounds of Formula (I-A), (I-B), and (I-C), pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof. Compounds of the present invention are useful for inhibiting Myc (e.g., c-Myc) activity. The p